Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 2/20 | 0.63 |
| ▸ | ACACA | Q13085 | 2/20 | 0.63 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.60 |
| ▸ | HSD11B1 | P28845 | 6/20 | 0.55 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13455191 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL1878720 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL982765 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL1878721 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL14047057 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL14520017 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL12152345 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL13420256 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL13801861 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL11408854 | 1.00 | ACLY (0.63) | ACLYACACAPTPN11HSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9987322-B1 | Treatment of pain in peripheral neuropathy using topical hamelia patens extract | BERRY DON WAYNE (US) | 2018-06-05 | — | — | US | claimed |
| US-9345736-B2 | Topical treatment of radiation dermatitis using hamelia patens | BERRY PHARMACEUTICALS, L.L.C. (US) | 2016-05-24 | — | — | US | claimed |
| US-9345737-B2 | Topical treatment of keratotic lesions using hamelia patens | BERRY PHARMACEUTICALS, L.L.C. (US) | 2016-05-24 | — | — | US | claimed |
| US-20140193478-A1 | Compositions and methods for treatment on mammalian skin | BERRY PHARMACEUTICALS, L.L.C. (US) | 2014-07-10 | — | — | US | claimed |
| US-20140193479-A1 | Compositions and methods for treatment of mammalian skin | BERRY PHARMACEUTICALS, L.L.C. (US) | 2014-07-10 | — | — | US | claimed |
| US-8652534-B2 | Compositions and methods for treatment of mammalian skin | Berry Pharmaceuticals, LLC (US) | 2014-02-18 | — | — | US | claimed |
| US-20130251825-A1 | Compositions and methods for treatment of mammalian skin | BERRY DON WAYNE (US) | 2013-09-26 | — | — | US | claimed |
| WO-2011126539-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF MAMMALIAN SKIN | BERRY PHARMACEUTICALS, L.L.C. (US) | 2011-10-13 | — | — | WO | claimed |
| US-20110086088-A1 | Compositions and methods for treatment of mammalian skin | BERRY PHARMACEUTICALS, L.L.C. | 2011-04-14 | — | — | US | claimed |
| US-20260101926-A1 | VAPORIZING DEVICE | MINSKOFF NOAH MARK (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4590133-A1 | ENHANCED HYDRATION BEVERAGES WITH IMPROVED TASTE | The Coca-Cola Company (US) | 2025-07-30 | — | — | EP | disclosed |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | ALKALAY RACHEL (IL) | 2024-11-28 | — | — | US | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| WO-2024186617-A1 | COMPOSITIONS CONTAINING GAMMA-AMINOBUTYRIC ACID AND METHODS FOR IMPROVING COGNITIVE FUNCTIONS, MOOD, AND ALERTNESS | THE COCA-COLA COMPANY (US) | 2024-09-12 | — | — | WO | disclosed |
| US-20120283217-A1 | MODULATORS OF AMYLOID-BETA PRODUCTION | SATORI PHARMACEUTICALS, INC. (US) | 2012-11-08 | — | — | US | disclosed |
| US-20120283217-A1 | MODULATORS OF AMYLOID-BETA PRODUCTION | SATORI PHARMACEUTICALS, INC. (US) | 2012-11-08 | — | — | US | disclosed |
| WO-2011126539-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF MAMMALIAN SKIN | BERRY PHARMACEUTICALS, L.L.C. (US) | 2011-10-13 | — | — | WO | disclosed |
| US-20110086088-A1 | Compositions and methods for treatment of mammalian skin | BERRY PHARMACEUTICALS, L.L.C. | 2011-04-14 | — | — | US | disclosed |
| US-20100056487-A1 | MODULATORS OF AMYLOID-BETA PRODUCTION | SATORI PHARMACEUTICALS, INC. (US) | 2010-03-04 | — | — | US | disclosed |
| US-20100056487-A1 | MODULATORS OF AMYLOID-BETA PRODUCTION | SATORI PHARMACEUTICALS, INC. (US) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260101926-A1 | VAPORIZING DEVICE | SARAF, HSF1, TFPI | ACLY 1619/4885ACACA 1356/4885PTPN11 4198/4885 |
| US-20120283217-A1 | MODULATORS OF AMYLOID-BETA PRODUCTION | APP, BACE1, BACE2 | ACLY 668/4885ACACA 195/4885PTPN11 4386/4885 |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | TPO, TNF, ADAMTS13 | ACLY 3385/4885ACACA 1097/4885PTPN11 1605/4885 |
| US-20100056487-A1 | MODULATORS OF AMYLOID-BETA PRODUCTION | APP, BACE1, BACE2 | ACLY 668/4885ACACA 195/4885PTPN11 4386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.